You can check out the annual or quarterly balance sheets of Kyverna Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

Total equity

Cash, cash equivalents and short-term investments

-5.79%199.43M

-2.56%236.45M

-2.35%279.25M

-46.78%171.14M

-38.86%211.68M

-34.38%242.65M

396.98%285.98M

316.16%321.59M

--346.24M

--369.79M

--57.54M

--77.27M

- Cash and cash equivalents

-40.48%31.81M

-43.39%32.19M

28.43%124.09M

-67.36%34.16M

-59.40%53.44M

-74.65%56.87M

178.87%96.62M

355.71%104.66M

--131.62M

--224.29M

--34.65M

--22.97M

-Short-term investments

5.93%167.62M

9.94%204.25M

-18.06%155.16M

-36.86%136.97M

-26.27%158.24M

27.68%185.78M

727.04%189.36M

299.44%216.92M

--214.62M

--145.51M

--22.90M

--54.31M

Prepaid expenses

168.49%7.12M

5.56%5.28M

-19.95%3.70M

0.00%3.79M

2.47%2.65M

-12.15%5.00M

48.09%4.62M

77.29%3.79M

--2.59M

--5.69M

--3.12M

--2.14M

Other current assets

--0.00

----

--0.00

----

Total current assets

-3.63%206.54M

-2.39%241.73M

-2.63%282.95M

-46.24%174.93M

-38.56%214.33M

-34.05%247.65M

379.03%290.60M

309.74%325.37M

--348.82M

--375.49M

--60.66M

--79.41M

Non-current assets

Net Fixed Assets

22.56%9.29M

10.56%9.73M

-49.15%5.42M

-44.46%6.32M

-39.41%7.58M

-30.97%8.80M

0.43%10.66M

2.81%11.38M

--12.51M

--12.75M

--10.61M

--11.07M

-Fixed Assets

6.67%12.57M

6.82%13.61M

-36.01%9.17M

-32.75%9.90M

-24.09%11.79M

-17.74%12.74M

9.39%14.33M

10.52%14.73M

--15.53M

--15.48M

--13.10M

--13.33M

-Accumulated depreciation

-21.91%3.29M

-1.55%3.87M

2.12%3.75M

7.08%3.58M

39.24%4.21M

44.00%3.93M

47.59%3.67M

48.38%3.35M

--3.02M

--2.73M

--2.49M

--2.25M

Other non-current assets

-13.23%4.00M

32.47%5.57M

60.98%5.45M

142.17%5.91M

157.64%4.60M

140.88%4.20M

-13.59%3.39M

21.70%2.44M

--1.79M

--1.74M

--3.92M

--2.00M

Total non-current assets

9.03%13.28M

17.64%15.30M

-22.58%10.87M

-11.51%12.23M

-14.78%12.18M

-10.29%13.00M

-3.35%14.04M

5.71%13.82M

--14.29M

--14.50M

--14.53M

--13.08M

Total assets

-2.95%219.82M

-1.39%257.02M

-3.55%293.83M

-44.82%187.16M

-37.62%226.51M

-33.16%260.65M

305.14%304.64M

266.75%339.20M

--363.12M

--389.98M

--75.19M

--92.49M

Liabilities

Current liabilities

-Other payables

-39.56%9.11M

-22.54%9.22M

-4.18%13.47M

117.04%13.96M

161.04%15.07M

286.18%11.91M

299.52%14.06M

117.96%6.43M

--5.78M

--3.08M

--3.52M

--2.95M

Accrued expenses

-17.73%9.23M

-26.42%6.86M

23.42%13.74M

23.57%13.21M

25.07%11.22M

22.54%9.33M

22.85%11.13M

31.89%10.69M

--8.97M

--7.61M

--9.06M

--8.11M

Short-term debt and lease liabilities

-56.85%126.00K

-56.41%221.00K

-60.59%307.00K

-79.59%190.00K

-70.89%292.00K

-48.21%507.00K

-18.51%779.00K

3.79%931.00K

--1.00M

--979.00K

--956.00K

--897.00K

-Short-term lease liabilities

-56.85%126.00K

-56.41%221.00K

-60.59%307.00K

-79.59%190.00K

-70.89%292.00K

-48.21%507.00K

-18.51%779.00K

3.79%931.00K

--1.00M

--979.00K

--956.00K

--897.00K

Other current liabilities

-39.56%9.11M

-22.54%9.22M

-4.18%13.47M

117.04%13.96M

161.04%15.07M

286.18%11.91M

299.52%14.06M

117.96%6.43M

--5.78M

--3.08M

--3.52M

--2.95M

Total current liabilities

-42.69%22.80M

-10.87%29.67M

8.09%36.49M

9.31%33.87M

69.47%39.79M

52.26%33.29M

69.98%33.76M

83.63%30.98M

--23.48M

--21.86M

--19.86M

--16.87M

Non-current liabilities

Long-term debt and lease liabilities

1258.89%31.47M

868.60%31.77M

502.48%25.06M

-73.21%1.33M

-59.52%2.32M

-49.23%3.28M

-20.58%4.16M

-13.84%4.97M

--5.72M

--6.46M

--5.24M

--5.77M

-Long-term debt

--24.88M

--24.81M

--24.74M

----

-Long-term lease liabilities

184.50%6.59M

112.13%6.96M

-92.31%320.00K

-73.21%1.33M

-59.52%2.32M

-49.23%3.28M

-20.58%4.16M

-13.84%4.97M

--5.72M

--6.46M

--5.24M

--5.77M

Other non-current liabilities

--0.00

----

--0.00

----

--296.00K

----

--0.00

Total non-current liabilities

1243.81%31.47M

847.51%31.77M

482.59%25.06M

-75.66%1.34M

-61.79%2.34M

-52.96%3.35M

-30.15%4.30M

-19.62%5.50M

--6.13M

--7.13M

--6.16M

--6.84M

Total liabilities

28.82%54.27M

67.67%61.44M

61.73%61.55M

-3.50%35.21M

42.30%42.13M

26.39%36.65M

46.28%38.06M

53.83%36.49M

--29.61M

--28.99M

--26.02M

--23.72M

Shareholders' equity

Common equity

25.05%668.57M

24.06%660.23M

23.96%657.01M

1.96%538.94M

1.82%534.63M

1.61%532.17M

11316.48%530.00M

14725.47%528.59M

--525.09M

--523.73M

--4.64M

--3.57M

Preferred equity

----

--180.57M

Retained earnings

-43.58%-502.87M

-50.75%-464.56M

-61.21%-424.83M

-71.23%-387.02M

-82.85%-350.24M

-89.36%-308.15M

-93.70%-263.52M

-95.91%-226.03M

---191.54M

---162.74M

---136.04M

---115.38M

Capital reserves

25.05%668.56M

24.06%660.23M

23.96%657.00M

1.96%538.94M

1.82%534.63M

1.61%532.17M

11317.54%530.00M

14727.15%528.59M

--525.09M

--523.73M

--4.64M

--3.56M

Gains losses not affecting retained earnings

-610.00%-142.00K

-9500.00%-96.00K

-7.62%97.00K

-81.05%29.00K

45.95%-20.00K

0.00%-1.00K

2525.00%105.00K

2960.00%153.00K

---37.00K

---1.00K

--4.00K

--5.00K

Total equity

-10.21%165.55M

-12.69%195.58M

-12.87%232.28M

-49.80%151.95M

-44.72%184.38M

-37.95%224.01M

442.10%266.59M

340.19%302.71M

--333.51M

--360.99M

--49.18M

--68.77M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing KYTX stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Kyverna Therapeutics Inc Have?



In its most recent quarterly, Kyverna Therapeutics Inc had 31.81M in cash and cash equivalents.

How Much Are Kyverna Therapeutics Inc's Total Liabilities?



Kyverna Therapeutics Inc reported 61.55M in total liabilities as of the latest reported quarter, including 36.49M in current liabilities and 25.06M in non-current liabilities.

What Are Kyverna Therapeutics Inc's Total Assets?



As of the latest reported quarter, Kyverna Therapeutics Inc's total assets were 293.83M, consisting of 282.95M in current assets and 10.87M in non-current assets.

How Much Shareholders' Equity Does Kyverna Therapeutics Inc Have?



Kyverna Therapeutics Inc reported 232.28M in total shareholders' equity as of the latest reported quarter.